IPS IPSOS

Ipsos: Appointment of Dr Bonnie Bain as Global Head of Healthcare

Ipsos: Appointment of Dr Bonnie Bain as Global Head of Healthcare

Paris, September 11, 2023 - I am pleased to announce that Dr Bonnie Bain, PhD has been appointed Global Head of Healthcare and will join us on 11th September. She will replace Michael Spedding, who retires at the end of the year.

Bonnie brings a wealth of valuable experience and expertise to the role and a wonderfully positive, inclusive approach. She has over 20 years' experience in the healthcare sector and a proven track record of developing innovative solutions on both the client and agency side of the business. Prior to joining Ipsos, she was Global Head of Pharma and Executive VP of Healthcare Operations & Strategy at GlobalData Plc. Under her leadership, GlobalData launched several premium syndicated, multi-client and custom offerings in the pharmaceutical and medical device sectors. Bonnie is also passionate about diversity and inclusion initiatives and served as the executive sponsor for GlobalData's Employee Resource Group on Race and Ethnicity.

Prior to joining GlobalData, Bonnie worked at several data analytics and consulting firms including Informa and Decision Resources Group. She was Vice President and Global Research & Analysis Director for Informa’s Pharma Division, where she successfully co-led the integration of Datamonitor Healthcare into Informa’s Pharma Intelligence business, revamped the portfolio, and launched new product and line extensions, resulting in double digit increases in profit. She also expanded the portfolio to include more rigorous primary research, epidemiology, emerging markets, and event-driven updates, and transformed the analyst team from a UK-centric team to an international presence based in the US, UK, India, and Asia-Pacific.

Bonnie is a frequent speaker at industry events and works closely with clients in a variety of industries including pharmaceuticals, medical devices, professional services, financial markets, and technology. She holds a Ph.D. in Biochemistry and Molecular Biology from Purdue University and completed a post-doctoral fellowship in Molecular Pharmacology at the University of Miami School of Medicine. She also holds a graduate certificate in applied management principles from Purdue University's Krannert School of Management.

Bonnie Bain’s track record and expertise should will help us in our focus on accelerating our development in the healthcare sector, where structural forces drive on-going growth” said Ben Page, Ipsos CEO.

Bonnie commented: “I am very excited to be taking on the role of Global Head of Healthcare and building on the success of the teams. I look forward to continuing to strengthen our core products, expanding our value-added services, exploring new ways to leverage technologies and internal collaborations to grow our business and best serve our clients”.

ABOUT IPSOS

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing nearly 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

“Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

 

 

 

 

 

 

 

 

 

Attachment



EN
11/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IPSOS

 PRESS RELEASE

Ipsos: Disclosure of trading in own shares under a share buyback progr...

Ipsos: Disclosure of trading in own shares under a share buyback programme (23 to 24 February 2026) 3rd March 2026 Disclosure of trading in own shares under a share buyback programme Period : From 23 to 24 February 2026 Issuer’s registered name: Ipsos Issuer’s Identification code: 9695002OY2X35E9X8W87 Financial instrument reference: Ordinary shares – ISIN code FR0000073298 Reporting of transactions in aggregated form (per day and per trading venue) Issuer nameIssuer CodeTransaction dateISIN CodeDaily total volume (in number of shares)Daily weighted average price of shares acquiredPla...

 PRESS RELEASE

Ipsos : Communiqué relatif aux rachats d’actions propres (23 au 24 fév...

Ipsos : Communiqué relatif aux rachats d’actions propres (23 au 24 février 2026) Le 3 mars 2026 Communiqué relatif aux rachats d’actions propres Période du 23 au 24 février 2026 Emetteur : Ipsos Code identifiant (LEI) de l’émetteur : 9695002OY2X35E9X8W87 Référence de l’instrument financier : Actions ordinaires – Code ISIN FR0000073298 Présentation agrégée par jour et par marché Nom de l'émetteurCode Identifiant de l'émetteurJour de la transactionCode identifiant de l'instrument financierVolume total journalier (en nombre d'actions)Prix pondéré moyen journalier d'acquisition des action...

IPS IPSOS
ELIS ELIS SA ... (+3)

Ipsos : Evolution de la couverture

Dans le cadre de la rotation du suivi de nos valeurs, nous arrêtons la couverture avec recommandation des émetteurs suivants : Apcoa, Bel, Elis, Ipsos, Klöckner Pentaplast et Spie. Les précédents avis crédit et recommandations de marché sont listés dans le tableau ci-dessous. Nous continuerons de suivre le newsflow de ces émetteurs dans le Morning crédit (suivi light). Nous comptons prochainement initier la couverture de nouveaux émetteurs. Emetteur Précédent avis crédit Précédente reco marché ...

IPS IPSOS
ELIS ELIS SA ... (+3)

Ipsos : Evolution of coverage

As part of the rotation of our coverage, we are terminating the coverage with recommendation of the following issuers: Apcoa, Bel, Elis, Ipsos, Klöckner Pentaplast and Spie. The previous credit opinions and market recommendations are listed in the table below. We will continue to follow the newsflow of these issuers in the Credit Morning (light coverage). We plan to initiate the coverage of new issuers soon. Issuer Previous credit opinion Previous market reco Date of the last report Current cov...

 PRESS RELEASE

[Press Release] Launch of a share buyback programme

[Press Release] Launch of a share buyback programme Launch of a share buyback programme Paris, March 2, 2026 - As announced during the presentation of Ipsos’ 2025 annual results, which were the subject of a press release dated February 24, 2026, the Company’s capital allocation and shareholder return priorities include the launch of a new share buyback programme. This programme is in addition to the recurring share buybacks implemented to offset the dilution resulting from free share plans granted to managers and employees. The Company announces today that, by December 31, 2026, it will ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch